Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | CASP6 | P55212 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL63159 | 0.83 | ACHE (0.62) | ACHETSHRKDM4ECASP6MAPT | |
| SCHEMBL28917348 | 0.82 | CYP4F2 (0.44) | ACHEKDM4ECASP6 | |
| SCHEMBL9066971 | 0.77 | TDP1 (0.42) | TSHRKDM4EMAPT | |
| SCHEMBL27618715 | 0.77 | DAO (0.43) | TSHRMAPT | |
| SCHEMBL28116263 | 0.75 | ACHE (0.48) | ACHETSHRKDM4ECASP6MAPT | |
| SCHEMBL28093078 | 0.73 | SMN1; SMN2 (0.41) | TSHRKDM4EMAPTRECQL | |
| SCHEMBL9999570 | 0.73 | ACHE (0.53) | ACHETSHRKDM4ECASP6MAPT | |
| SCHEMBL20649211 | 0.73 | ACHE (0.53) | ACHETSHRKDM4ECASP6MAPT | |
| SCHEMBL231469 | 0.73 | — | — | |
| SCHEMBL30539351 | 0.71 | ACHE (0.50) | ACHETSHRKDM4ECASP6MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106279162-A | One-dimensional organic semiconductor nanowires/band that organophosphorus compound toxic gas is had fluorescence response and its preparation method and application | 中国科学院化学研究所 | 2017-01-04 | — | — | CN | claimed |
| US-20240115511-A1 | NANOMATERIALS COMPRISING AN IONIZABLE LIPID | BEAM THERAPEUTICS INC. | 2024-04-11 | — | — | US | disclosed |
| EP-4281050-A1 | NANOMATERIALS | Beam Therapeutics Inc. (US) | 2023-11-29 | — | — | EP | disclosed |
| EP-4281064-A1 | NANOMATERIALS COMPRISING AN IONIZABLE LIPID | Beam Therapeutics Inc. (US) | 2023-11-29 | — | — | EP | disclosed |
| CN-106279162-A | One-dimensional organic semiconductor nanowires/band that organophosphorus compound toxic gas is had fluorescence response and its preparation method and application | 中国科学院化学研究所 | 2017-01-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240115511-A1 | NANOMATERIALS COMPRISING AN IONIZABLE LIPID | LIPA, SGMS2, PHOSPHO1 | ACHE 2875/4885TSHR 3172/4885KDM4E 4244/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.